Difference between revisions of "Category:Myeloproliferative neoplasms"
Jump to navigation
Jump to search
(→NCCN) |
m |
||
| Line 3: | Line 3: | ||
*[https://www.nccn.org/professionals/physician_gls/pdf/mpn.pdf NCCN Guidelines - Myeloproliferative Neoplasms] | *[https://www.nccn.org/professionals/physician_gls/pdf/mpn.pdf NCCN Guidelines - Myeloproliferative Neoplasms] | ||
*'''2016:''' Mesa et al. [https://doi.org/10.6004/jnccn.2016.0169 Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology] [https://pubmed.ncbi.nlm.nih.gov/27956542/ PubMed] | *'''2016:''' Mesa et al. [https://doi.org/10.6004/jnccn.2016.0169 Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology] [https://pubmed.ncbi.nlm.nih.gov/27956542/ PubMed] | ||
| − | |||
| − | |||
=Diagnostic criteria= | =Diagnostic criteria= | ||
*'''2022:''' Arber et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479031/ International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data] | *'''2022:''' Arber et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479031/ International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data] | ||
| + | |||
| + | [[Category:Myeloid neoplasms]] | ||
Revision as of 17:43, 30 March 2024
Guidelines
NCCN
- NCCN Guidelines - Myeloproliferative Neoplasms
- 2016: Mesa et al. Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology PubMed
Diagnostic criteria
Pages in category "Myeloproliferative neoplasms"
The following 15 pages are in this category, out of 15 total.